Larotaxel CAS No.156294-36-9
Larotaxel CAS No.156294-36-9
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1512 | 2mg | 310.00 | + Add to cart |
|
| R-R-1512 | 5mg | 620.00 | + Add to cart |
|
|
|
||||
Product description
Larotaxel (XRP9881)/CAS No.156294-36-9 is a taxane analogue with preclinical activity against taxane-resistant breast cancer. Larotaxel (XRP9881) exerts its cytotoxic effect by promoting tubulin assembly and stabilizing microtubules, ultimately leading to cell death by apoptosis. It presents the ability to cross the blood brain barrier and has a much lower affinity for P-glycoprotein 1 than Docetaxel.
| Appearance | N/A |
|---|---|
| Molecular Weight | 831.90 |
| Purity | >90% |
| CAS | 156294-36-9 |
| Formula | C45H53NO14 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Larotaxel CAS No.156294-36-9
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


